Paper Details

  1. Home
  2. Paper Details

[Virus specific antibody - based remedies for the urgent prevention and treatment of Ebola virus disease].

Author: BorisevichS V, LebedevV N, SizikovaT E

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Ebola virus is highly infectious with a mortality rate reaching 90%. This review examines therapeutic approaches for both prophylaxis and treatment of Ebola virus disease, focusing on therapies based on virus-specific antibodies.
Paper Details　
Original Abstract of the Article :
The Ebola virus (member of Ebolavirus genus Filoviridae family) is the etiologic agent of extremely hazard human disease with high mortality rates (up to 90%). The most important components of spectrum of therapeutics for special prophylactic and current of disease, caused by Ebola virus, are prepar...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.26442/00403660.2019.11.000164

データ提供：米国国立医学図書館（NLM）

Ebola Virus Disease: Exploring Antibody-Based Therapeutics

Ebola virus disease (EVD) is a highly contagious and often fatal disease, presenting a serious threat to global health. This review explores the potential of virus-specific antibody-based therapies for the prevention and treatment of EVD. The authors discuss the use of convalescent plasma, heterologous immunoglobulins, and monoclonal antibodies in the fight against Ebola virus.

Antibody-Based Therapies: A Promising Approach to EVD

The review highlights the potential of antibody-based therapies as a promising approach to EVD. These therapies offer the advantage of targeting the virus directly, potentially interrupting its replication and reducing disease severity. The authors emphasize the need for further research and development to optimize the composition and application of these therapies for maximum effectiveness.

Navigating the Desert of Viral Infections

Emerging viral infections, like EVD, can be a formidable challenge, like navigating a vast and unforgiving desert. This review provides a valuable overview of promising therapeutic approaches, specifically focusing on antibody-based therapies. The authors emphasize the importance of continued research and development to combat these infectious threats.

Dr.Camel's Conclusion

This review provides a comprehensive overview of antibody-based therapies for EVD, highlighting their potential as a powerful weapon in the fight against this deadly disease. The authors emphasize the need for continued research and development to optimize these therapies, offering hope for improved treatment outcomes and a greater chance of survival in the face of this formidable viral threat.

Date :
  1. Date Completed 2020-09-17
  2. Date Revised 2020-09-17
Further Info :

Pubmed ID

32598619

DOI: Digital Object Identifier

10.26442/00403660.2019.11.000164

Related Literature

Article Analysis
・Effective treatment of ebola
SNS
PICO Info
in preparation
Languages

Russian

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.